Evidence for endotoxin contamination in plastic Na+-heparin blood collection tube lots

Clinical Chemistry

Volumn 56, Issue 9, 2010, Pages 1483-1491

  Newhall, Kathryn J ^a   Diemer, Geoffrey S ^a   Leshinsky, Natalia ^a   Kerkof, Keith ^a   Chute, Hilary T ^b   Russell, Chris B ^a   Rees, William ^a   Welcher, Andrew A ^b   Patterson, Scott D ^b   Means, Gary D ^a  

^a AMGEN INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DNA; ENDOTOXIN; HEPARIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOPROTEIN; RNA; SODIUM; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD SAMPLING; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEPARINIZATION; HUMAN; HUMAN EXPERIMENT; INCUBATION TEMPERATURE; LIMULUS LYSATE TEST; NORMAL HUMAN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION;

ANTICOAGULANTS; BIOLOGICAL MARKERS; BLOOD SPECIMEN COLLECTION; C-REACTIVE PROTEIN; CHEMOKINE CCL2; CHEMOKINE CCL7; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EQUIPMENT CONTAMINATION; FLOW CYTOMETRY; HEPARIN; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLASTICS; RNA, MESSENGER; SERUM AMYLOID P-COMPONENT; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956387857     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2006.144618     Document Type: Article

References (12)

1. US Department of Health and Human Services, Food and Drug Administration. Innovation or stagnation: challenge and opportunity on the critical path to new medical products. http://www. fda.gov/ScienceResearch/SpecialTopics/Critical PathInitiative/CriticalPathOpportunitiesReports/ ucm077262.htm (Accessed July 2010).
2. Schrohl A-S, Würtz S, Kohn E, Banks RE, Nielsen HJ, Sweep FCGJ, Brünner N. Banking of biological fluids for studies of disease-associated protein biomarkers. Mol Cell Proteomics 2008;7:2061-66.
3. Carraro P, Plebani M. Errors in a STAT laboratory: types and frequencies 10 years later. Clin Chem 2007;53:1338-42.
4. Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem 2002; 48:691-8.
5. Plebani M, Carraro P. Mistakes in a STAT laboratory: types and frequency. Clin Chem 1997; 43:1348-51. (Pubitemid 27329780)
6. Remvig L, Enk C, Baek L, Bendtzen K. Influence of endotoxin on production of leukocyte migration inhibition factor, part I. J Immunol Methods 1984; 72:189-96. (Pubitemid 14092008)
7. Wallis RS, Fujiwara H, Ellner JJ. Direct stimulation of monocyte release of interleukin 1 by mycobacterial protein antigens. J Immunol 1986;136: 193-6. (Pubitemid 16232172)
8. Redl H, Bahrami S, Leichtfried G, Schiag G. Special Collection And Storage Tubes For Blood Endotoxin And Cytokine Measurements. Clin Chem 1992;38:764-5.
9. Riches P, Gooding R, Millar BC, Rowbottom AW. Influence of collection and separation of blood samples on plasma IL-1, IL-6, and TNF-α concentrations. J Immunol Methods 1992;153:125-31.
10. Aziz N, Irwin MR, Dickerson SS, Butch AW. Spurious tumor necrosis factor-alpha and interleukin-6 production by human monocytes from blood collected in endotoxin-contaminated Vacutainer blood. Clin Chem 2004;50:2215-6. (Pubitemid 39425878)
11. Broad A, Jones DEJ, Kirby JA. Toll-like receptor (TLR) response tolerance: a key physiological "damage limitation" effect and an important potential opportunity for therapy. Current Med Chem 2006;13:2487-502.
12. Ertel W, Kremer J, Kenny J, Steckholzer U, Jarrar D, Trentz O, Schildberg FW. Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 1995;85:1341-7.